Nordic Life Sciences Database

STOCKHOLM, Jan. 29, 2020 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that an order of more Rabeximod substance will be placed earlier than expected with the primary objective of providing optimal conditions for conducting the clinical phase IIb... Read more ››

By: PR Newswire Association LLC. - 29 Jan 2020

Related companies: Cyxone AB

Reminder: C-RAD Web Presentation Year-end Report 2019

By: GlobenewsWire - 29 Jan 2020

Related companies: C-RAD AB

Trading by management and close relations of management

By: GlobenewsWire - 28 Jan 2020

Related companies: Novozymes A/S

Essity Raises EUR 300m in the Bond Market

STOCKHOLM, Jan. 28, 2020 /PRNewswire/ -- Essity has today raised EUR 300m in the bond market under its Euro Medium Term Note (EMTN) program. The reoffering yield for the bond was 0.58% with a maturity on February 3, 2030, corresponding to mid swaps +0.58 percentage points.

By: PR Newswire Association LLC. - 28 Jan 2020

Related companies: Essity Aktiebolag

Bavarian Nordic Announces Appointment of Laurence De Moerlooze as Chief Medical Officer

By: GlobenewsWire - 28 Jan 2020

Related companies: Bavarian Nordic A/S

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 28 Jan 2020

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 28 Jan 2020

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 28 Jan 2020

Related companies: IBEX Technologies Inc. | Infant Bacterial Therapeutics AB

Trading by management and close relations of management

By: GlobenewsWire - 27 Jan 2020

Related companies: Novozymes A/S

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Looking for companies outside of the Nordic countries?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

April 2020
- Online: BioTrinity 2020 - DIGITAL EVENT
May 2020
- : Venture Summit | West
- Vienna: Nano Drug Delivery 2020

See Events »

Add an Event »

Latest company news

There are currently no news available for this portal

Visit the global news page on Biotechgate »

News in the Life Sciences Industry

Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Aino Health AB (publ): Aino Health signs new customer: Kaksineuvoinen

Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S

Chr. Hansen Holding A/S - Major shareholder announcement from BlackRock, Inc.

Cyxone Orders More Rabeximod Substance and Confirms Timeline for the Phase IIb Program

Reminder: C-RAD Web Presentation Year-end Report 2019

Trading by management and close relations of management

Essity Raises EUR 300m in the Bond Market

Bavarian Nordic Announces Appointment of Laurence De Moerlooze as Chief Medical Officer

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Novo Nordisk A/S – Share repurchase programme

Novo Nordisk A/S – Share repurchase programme

IBEX Grants Stock Options

Trading by management and close relations of management

Sanofi: Disclosure of trading in own shares

Sanofi: Disclosure of trading in own shares

Sanofi: Disclosure of trading in own shares

Looking for companies outside of the Nordic countries?

Partners

Upcoming Life Sciences Events

Latest company news